Literature DB >> 22072561

Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model.

Sungheon Kim1, Lindsey Decarlo, Gene Y Cho, Jens H Jensen, Daniel K Sodickson, Linda Moy, Silvia Formenti, Robert J Schneider, Judith D Goldberg, Eric E Sigmund.   

Abstract

The effective delivery of a therapeutic drug to the core of a tumor is often impeded by physiological barriers, such as the interstitial fluid pressure (IFP). There are a number of therapies that can decrease IFP and induce tumor vascular normalization. However, a lack of a noninvasive means to measure IFP hinders the utilization of such a window of opportunity for the maximization of the treatment response. Thus, the purpose of this study was to investigate the feasibility of using intravoxel incoherent motion (IVIM) diffusion parameters as noninvasive imaging biomarkers for IFP. Mice bearing the 4T1 mammary carcinoma model were studied using diffusion-weighted imaging (DWI), immediately followed by wick-in-needle IFP measurement. Voxelwise analysis was conducted with a conventional monoexponential diffusion model, as well as a biexponential model taking IVIM into account. There was no significant correlation of IFP with either the median apparent diffusion coefficient from the monoexponential model (r = 0.11, p = 0.78) or the median tissue diffusivity from the biexponential model (r = 0.30, p = 0.44). However, IFP was correlated with the median pseudo-diffusivity (D(p)) of apparent vascular voxels (r = 0.76, p = 0.02) and with the median product of the perfusion fraction and pseudo-diffusivity (f(p)D(p)) of apparent vascular voxels (r = 0.77, p = 0.02). Although the effect of IVIM in tumors has been reported previously, to our knowledge, this study represents the first direct comparison of IVIM metrics with IFP, with the results supporting the feasibility of the use of IVIM DWI metrics as noninvasive biomarkers for tumor IFP.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22072561      PMCID: PMC3883504          DOI: 10.1002/nbm.1793

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  46 in total

1.  Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique.

Authors:  R Wirestam; M Borg; S Brockstedt; A Lindgren; S Holtås; F Ståhlberg
Journal:  Acta Radiol       Date:  2001-03       Impact factor: 1.990

2.  In vivo MR measurements of regional arterial and venous blood volume fractions in intact rat brain.

Authors:  T Q Duong; S G Kim
Journal:  Magn Reson Med       Date:  2000-03       Impact factor: 4.668

3.  Imaging the microcirculatory proton fraction of muscle with diffusion-weighted echo-planar imaging.

Authors:  L Yao; U Sinha
Journal:  Acad Radiol       Date:  2000-01       Impact factor: 3.173

4.  Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI.

Authors:  Z Wang; M Y Su; A Najafi; O Nalcioglu
Journal:  Magn Reson Imaging       Date:  2001-10       Impact factor: 2.546

Review 5.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

6.  Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer.

Authors:  E E Sigmund; G Y Cho; S Kim; M Finn; M Moccaldi; J H Jensen; D K Sodickson; J D Goldberg; S Formenti; L Moy
Journal:  Magn Reson Med       Date:  2011-02-01       Impact factor: 4.668

Review 7.  Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize.

Authors:  Dai Fukumura; Rakesh K Jain
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

8.  Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer.

Authors:  Masoom A Haider; Igor Sitartchouk; Timothy P L Roberts; Anthony Fyles; Ali T Hashmi; Michael Milosevic
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

9.  "Artificial lymphatic system": a new approach to reduce interstitial hypertension and increase blood flow, pH and pO2 in solid tumors.

Authors:  G R DiResta; J Lee; J H Healey; A Levchenko; S M Larson; E Arbit
Journal:  Ann Biomed Eng       Date:  2000-05       Impact factor: 3.934

10.  Enhancing the uptake of chemotherapeutic drugs into tumors using an "artificial lymphatic system".

Authors:  G R DiResta; J Lee; J H Healey; S M Larson; E Arbit
Journal:  Ann Biomed Eng       Date:  2000-05       Impact factor: 3.934

View more
  26 in total

1.  Are we ready to image the incoherent molecular motion in our minds?

Authors:  Sotirios Bisdas
Journal:  Neuroradiology       Date:  2013-04-21       Impact factor: 2.804

2.  Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI.

Authors:  P Mürtz; A M Sprinkart; M Reick; C C Pieper; A-H Schievelkamp; R König; H H Schild; W A Willinek; G M Kukuk
Journal:  Eur Radiol       Date:  2018-04-18       Impact factor: 5.315

3.  Intravoxel Incoherent Motion of Colon Cancer Liver Metastases for the Assessment of Response to Antiangiogenic Treatment: Results from a Pilot Study.

Authors:  Ayşegül Öz; Sadık Server; Bedriye Koyuncu Sökmen; Esat Namal; Nagihan İnan; Numan Cem Balcı
Journal:  Med Princ Pract       Date:  2020-01-09       Impact factor: 1.927

4.  Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors.

Authors:  Gene Young Cho; Linda Moy; Sungheon G Kim; Steven H Baete; Melanie Moccaldi; James S Babb; Daniel K Sodickson; Eric E Sigmund
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

5.  Intravoxel incoherent motion analysis of abdominal organs: computation of reference parameters in a large cohort of C57Bl/6 mice and correlation to microvessel density.

Authors:  Christian Eberhardt; Moritz C Wurnig; Andrea Wirsching; Cristina Rossi; Markus Rottmar; Pinar S Özbay; Lukas Filli; Mickael Lesurtel; Andreas Boss
Journal:  MAGMA       Date:  2016-04-19       Impact factor: 2.310

6.  Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy.

Authors:  Guido M Kukuk; Petra Mürtz; Frank Träber; Carsten Meyer; Jan Ullrich; Jürgen Gieseke; Hojjat Ahmadzadehfar; Samer Ezziddin; Hans H Schild; Winfried A Willinek
Journal:  Eur Radiol       Date:  2013-10-01       Impact factor: 5.315

7.  Comparison of fitting methods and b-value sampling strategies for intravoxel incoherent motion in breast cancer.

Authors:  Gene Young Cho; Linda Moy; Jeff L Zhang; Steven Baete; Riccardo Lattanzi; Melanie Moccaldi; James S Babb; Sungheon Kim; Daniel K Sodickson; Eric E Sigmund
Journal:  Magn Reson Med       Date:  2014-10-09       Impact factor: 4.668

Review 8.  High-field small animal magnetic resonance oncology studies.

Authors:  Louisa Bokacheva; Ellen Ackerstaff; H Carl LeKaye; Kristen Zakian; Jason A Koutcher
Journal:  Phys Med Biol       Date:  2013-12-30       Impact factor: 3.609

9.  Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma.

Authors:  Louisa Bokacheva; Jennifer B Kaplan; Dilip D Giri; Sujata Patil; Merlin Gnanasigamani; C Gregory Nyman; Joseph O Deasy; Elizabeth A Morris; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2013-11-22       Impact factor: 4.813

10.  Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer.

Authors:  Harri Merisaari; Pekka Taimen; Rakesh Shiradkar; Otto Ettala; Marko Pesola; Jani Saunavaara; Peter J Boström; Anant Madabhushi; Hannu J Aronen; Ivan Jambor
Journal:  Magn Reson Med       Date:  2019-11-08       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.